OpGen, Inc.
(NASDAQ : OPGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -3.74%110.817.5%$299.73m
CPRTCopart, Inc. -2.39%110.614.4%$151.15m
CRLCharles River Laboratories International, Inc. -1.90%206.814.4%$133.09m
EFXEquifax, Inc. -2.71%169.602.0%$125.27m
FLTFLEETCOR Technologies, Inc. -0.89%180.624.0%$117.79m
BAHBooz Allen Hamilton Holding Corp. -0.38%96.212.1%$76.53m
MEDPMedpace Holdings, Inc. -3.25%162.801.1%$74.81m
PAGSPagSeguro Digital Ltd. -1.13%15.360.0%$55.29m
FCNFTI Consulting, Inc. -0.62%170.595.8%$48.02m
SYNHSyneos Health, Inc. -3.54%48.290.0%$47.23m
MQMarqeta, Inc. -3.43%7.190.0%$44.64m
GGenpact Ltd. -2.85%44.347.2%$42.82m
RCMR1 RCM, Inc. -3.44%17.980.0%$42.18m
FOURShift4 Payments, Inc. -2.54%47.160.0%$36.53m
EXELExelixis, Inc. -0.64%15.505.9%$36.16m

Company Profile

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.